Status:
UNKNOWN
Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
SIRS
Sepsis
Eligibility:
All Genders
18-80 years
Brief Summary
In this study patients with 1. chronicle liver diseases * primary biliary cirrhosis * primary sclerosing cholangitis * alcoholic liver cirrhosis * hepatitis b or C * Wilson's disease ...
Eligibility Criteria
Inclusion
- SIRS
- sepsis
- septic shock
- chronicle liver disease (MELD-Score \>10)
- patient after lysis
- patient agrees
Exclusion
- no agreement
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01169168
Start Date
April 1 2010
Last Update
July 26 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johann Wolfgang Goethe University Hospital
Frankfurt am Main, Hesse, Germany, 60590